YAMILA MELENDEZ: Open Payments
NPI 1790105286 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$69,902 in 109 payments from 6 companies in 2025. Trend: 2023 $32,662 · 2024 $47,665 · 2025 $69,902
Speaker / faculty: $49,800Travel & lodging: $16,974Food & beverage: $3,128
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 40 | $33,562 |
| Genmab U.S., Inc. | 37 | $18,104 |
| BeiGene USA, Inc. | 26 | $16,558 |
| ABBVIE INC. | 3 | $1,480 |
| Adaptive Biotechnologies Corporation | 2 | $112 |
| Genentech, Inc. | 1 | $86 |
Products named: BRUKINSA, Epkinly, clonoSEQ, Lunsumio.
Industry payments across FL — which companies pay providers there.
